BACKGROUND/ OBJECTIVE:Exercise interventions improve anxiety and mood disturbances in patients with cancer. However, studies are limited in older adults with cancer. We assessed the effects of exercise on anxiety, mood, and social and emotional well-being in older patients with cancer during their first 6 weeks of chemotherapy. DESIGN: Exploratory secondary analysis of a randomized controlled trial (RCT). SETTING: Community oncology practices. PARTICIPANTS: Older patients (aged 60 years or older) undergoing chemotherapy (N = 252). INTERVENTION: Patients were randomized to Exercise for Cancer Patients (EXCAP) or usual care (control) for the first 6 weeks of chemotherapy. EXCAP is a home-based, low- to moderate-intensity progressive walking and resistance training program. MEASUREMENTS: Analysis of covariance, with study arm as the factor, baseline value as the covariate, and study arm × baseline interaction, was used to evaluate arm effects on postintervention anxiety (State Trait Anxiety Inventory [STAI]), mood (Profile of Mood States [POMS]), and social and emotional well-being (Functional Assessment of Cancer Therapy-General subscales) after 6 weeks. RESULTS:Median age was 67 years; 77% had breast cancer. Statistically significant group differences were observed in the STAI score (P = .001), POMS score (P = .022), social well-being (P = .002), and emotional well-being (P = .048). For each outcome, EXCAP patients with worse baseline scores had larger improvements at 6 weeks; these improvements were clinically significant for STAI score and social well-being. CONCLUSIONS: Among older cancer patients receivingchemotherapy, a 6-week structured exercise program improved anxiety and mood, especially among those participants with worse baseline symptoms. Additional RCTs are needed to confirm these findings and evaluate the appropriate exercise prescription for managing anxiety, mood, and well-being in this patient population. J Am Geriatr Soc 67:1005-1011, 2019.
RCT Entities:
BACKGROUND/ OBJECTIVE: Exercise interventions improve anxiety and mood disturbances in patients with cancer. However, studies are limited in older adults with cancer. We assessed the effects of exercise on anxiety, mood, and social and emotional well-being in older patients with cancer during their first 6 weeks of chemotherapy. DESIGN: Exploratory secondary analysis of a randomized controlled trial (RCT). SETTING: Community oncology practices. PARTICIPANTS: Older patients (aged 60 years or older) undergoing chemotherapy (N = 252). INTERVENTION: Patients were randomized to Exercise for CancerPatients (EXCAP) or usual care (control) for the first 6 weeks of chemotherapy. EXCAP is a home-based, low- to moderate-intensity progressive walking and resistance training program. MEASUREMENTS: Analysis of covariance, with study arm as the factor, baseline value as the covariate, and study arm × baseline interaction, was used to evaluate arm effects on postintervention anxiety (State Trait Anxiety Inventory [STAI]), mood (Profile of Mood States [POMS]), and social and emotional well-being (Functional Assessment of Cancer Therapy-General subscales) after 6 weeks. RESULTS: Median age was 67 years; 77% had breast cancer. Statistically significant group differences were observed in the STAI score (P = .001), POMS score (P = .022), social well-being (P = .002), and emotional well-being (P = .048). For each outcome, EXCAP patients with worse baseline scores had larger improvements at 6 weeks; these improvements were clinically significant for STAI score and social well-being. CONCLUSIONS: Among older cancerpatients receiving chemotherapy, a 6-week structured exercise program improved anxiety and mood, especially among those participants with worse baseline symptoms. Additional RCTs are needed to confirm these findings and evaluate the appropriate exercise prescription for managing anxiety, mood, and well-being in this patient population. J Am Geriatr Soc 67:1005-1011, 2019.
Authors: Frank Baker; Maxine Denniston; James Zabora; Adrienne Polland; William N Dudley Journal: Psychooncology Date: 2002 Jul-Aug Impact factor: 3.894
Authors: Kathleen J Yost; Mark V Sorensen; Elizabeth A Hahn; G Alastair Glendenning; Ari Gnanasakthy; David Cella Journal: Value Health Date: 2005 Mar-Apr Impact factor: 5.725
Authors: Kah Poh Loh; Chandrika Sanapala; Grace Di Giovanni; Heidi D Klepin; Michelle Janelsins; Rebecca Schnall; Eva Culakova; Paula Vertino; Martha Susiarjo; Jason H Mendler; Jane L Liesveld; Po-Ju Lin; Richard F Dunne; Ian Kleckner; Karen Mustian; Supriya G Mohile Journal: J Geriatr Oncol Date: 2021-03-04 Impact factor: 3.929
Authors: S Yilmaz; M C Janelsins; M Flannery; E Culakova; M Wells; P-J Lin; K P Loh; R Epstein; C Kamen; A S Kleckner; S A Norton; S Plumb; S Alberti; K Doyle; M Porto; M Weber; N Dukelow; A Magnuson; L A Kehoe; G Nightingale; M Jensen-Battaglia; K M Mustian; S G Mohile Journal: J Geriatr Oncol Date: 2022-03-12 Impact factor: 3.929
Authors: Kah Poh Loh; Chandrika Sanapala; Michelle Janelsins; Heidi D Klepin; Rebecca Schnall; Eva Culakova; Michael B Sohn; Paula Vertino; Martha Susiarjo; Marielle Jensen-Battaglia; Michael W Becker; Jane Liesveld; Jason H Mendler; Eric Huselton; Po-Ju Lin; Karen Mustian Journal: J Geriatr Oncol Date: 2021-12-21 Impact factor: 3.929
Authors: Cynthia C Forbes; Flavia Swan; Sarah L Greenley; Michael Lind; Miriam J Johnson Journal: J Cancer Surviv Date: 2020-04-24 Impact factor: 4.442
Authors: Ian R Kleckner; Todd A Jusko; Eva Culakova; Kaitlin Chung; Amber S Kleckner; Matthew Asare; Julia E Inglis; Kah Poh Loh; Luke J Peppone; Jessica Miller; Marianne Melnik; Samer Kasbari; Deborah Ossip; Karen M Mustian Journal: Breast Cancer Res Treat Date: 2021-06-30 Impact factor: 4.624